专利号:US-2024309003-A1 优先权日:2021-05-04 标题 :Heterocyclic compounds as triggering receptor expressed on myeloid cells 2 agonists and methods of use 发明人:HOUZE JONATHAN B; BOS MAXENCE; MANCUSO JOHN; FRANZONI IVAN; PANDYA BHAUMIK; KAPLAN ALAN 权利人:VIGIL NEUROSCIENCE INC 摘要:The present disclosure provides compounds of Formula I, useful for the activation of Triggering Receptor Expressed on Myeloid Cells 2 (“TREM2â€?). This disclosure also provides pharmaceutical compositions comprising the compounds, uses of the compounds, and compositions for treatment of, for example, a neurodegenerative disorder. Further, the disclosure provides intermediates useful in the synthesis of compounds of Formula I.
参考文献:10.1007/bf00758446 摘要:Itov ZI, Gunar VI. Methods of synthesis and technology of production of drugs synthesis of pyridoxine (review). Pharmaceutical Chemistry Journal. 1988 Feb;22(2):151–7. doi: 10.1007/bf00758446. 参考文献:10.1007/s10593-019-02442-4 摘要:Slobodyanyuk EY, Volochnyuk DM. Decoration of 1,3-oxazole by alkyl substituents via CH activation (microreview). Chemistry of Heterocyclic Compounds. 2019 Mar;55(3):202–4. doi: 10.1007/s10593-019-02442-4.